fda approved glp 1 pill US Approves Wegovy for Weight Loss FDA approves Wegovy weight-loss GLP-1

The REDEFINE 3 cardiovascular outcomes trial which will take several years to complete is not a prerequisite for initial market authorisation for obesity treatment, but its results will likely be important for subsequent label expansion and for establishing the cardiovascular benefit profile that has proven so valuable for tirzepatide and semaglutide

Chen C, Zheng X, Wang C, Zhou H, Zhang Y, Ye T, Yang Y

Beneficial effect of a novel pentadecapeptide BPC 157 on gastric lesions induced by restraint stress, ethanol, indomethacin, and capsaicin neurotoxicity

Moreover, evidence on the long-term efficacy and safety of prolonged use, as well as combination therapy with other drugs, remains insufficient

While mild to moderate fatigue is common with GLP-1s, it should not be debilitating

Vitamin E Dry, damaged strands prone to split ends and breakage indicate Vitamin E deficiency